Kurma Partners is a European venture capital firm focused on funding healthcare and biotechnology companies. They invest across various stages of maturity, from company creation to capital expansion, emphasizing a strong network of partners with leading European academic research institutions. Their strategy involves transforming disruptive scientific discoveries into cutting-edge medicines or medical devices aimed at diagnosing and treating patients with severe diseases and high unmet medical needs. The firm actively works with research teams early on to validate discoveries, bringing together healthcare industry experts and experienced entrepreneurs to build high-tech companies. They provide initial capital/funding and invite other investors to participate. They support early-stage companies by offering expertise and their network. Kurma Partners is committed to sustainable development and adheres to established ESG practices. They aim to build the healthcare industry of tomorrow by collaborating with leading European research centers.
Preferred startup development maturity for initial funding deployment.
Healthcare, Biotechnology, Pharmaceuticals, Medical Devices
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...